
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+3
ABL Bio Inc. (Kosdaq: 298380) is a South Korean biotechnology company dedicated to the development of bispecific antibody therapeutics to improve and save peoples lives. With our BsAb platforms Grabody-T, Grabody-I and Grabody-B, we have built a robust pipeline of multiple clinical and pre-clinical stage drug candidates. In the oncology area, we have developed Grabody-T, a modular 4-1BB engaging platform that has demonstrated excellent efficacy and safety. We also created a next-generation antibody drug conjugate program to treat various cancers. In the neurodegenerative disorder space, we have developed Grabody-B platform, which is designed to maximize blood-brain barrier (BBB) penetration. Grabody-B...
Biotechnology,bispecific antibody,bbb penetration,immuno-oncology,adc,4-1bb,neurodegeneration,and antibody
Abl bio inc operates in the Biotechnology research industry.
Abl bio inc's revenue is 11m - 100m
Abl bio inc has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.